Although the accumulation of extracellular amyloid-β peptide (Aβ) and the aggregation of intracellular hyperphosphorylated tau have been identified as the two key pathological hallmarks of AD [4, 5], its specific pathogenesis and underlying mechanisms are not yet fully understood. The gene discussed is MAPT; the disease is Alzheimer disease.